NCT06403488View on ClinicalTrials.gov

Letrozole Dose Increments in PCOS Patients Resistant to Letrozole

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

January 30, 2024

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Letrozole 2.5mg

specific aromatase inhibitor

Trial Locations (2)

62511

Beni-suef university Hospital, Banī Suwayf

62521

Beni-suef university Hospital, Banī Suwayf

All Listed Sponsors
lead

Beni-Suef University

OTHER

NCT06403488 - Letrozole Dose Increments in PCOS Patients Resistant to Letrozole | Biotech Hunter | Biotech Hunter